Roberto Iacone
Directeur Général chez Alentis Therapeutics AG
Profil
Roberto Iacone is the founder of Bright Peak Therapeutics AG, Ridgeline Therapeutics.
He is currently the Chief Executive Officer & Director at Alentis Therapeutics AG and a Venture Partner at Pureos Partners AG.
Dr. Iacone holds a doctorate degree from Università degli Studi di Napoli Federico II.
Postes actifs de Roberto Iacone
| Sociétés | Poste | Début |
|---|---|---|
Alentis Therapeutics AG
 Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Directeur Général | 29/07/2020 |
Pureos Partners AG
 Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Private Equity Investor | - |
Anciens postes connus de Roberto Iacone
| Sociétés | Poste | Fin |
|---|---|---|
| Ridgeline Therapeutics | Fondateur | - |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Head-Fixed Income Invts | - |
Formation de Roberto Iacone
| Università degli Studi di Napoli Federico II | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Finance |
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Health Technology |
| Ridgeline Therapeutics |